Add BrightSurf on Google Email

Addressing both flu and COVID-19 through a single, multitasking injection

A new multitasking substance has been identified to prevent and treat both flu and COVID-19 infections concurrently. The long-acting recombinant cytokine protein rhIL-7-hyFc demonstrated therapeutic and preventive effects against various respiratory diseases, including COVID-19, influenza virus, and respiratory syncytial virus.

SourcePohang University of Science & Technology (POSTECH)·JournalCell Reports Medicine·DateMar 18, 2024

Study finds high levels of job satisfaction among copy editors, little negative effects from pandemic

A new study from the University of Kansas found that copy editors experienced high job satisfaction despite the COVID-19 pandemic, with many reporting a passion for their work. The researchers also found that the pandemic did not significantly affect burnout or role overload among participants.

SourceUniversity of Kansas·JournalJournalism & Mass Communication Quarterly·TypeSurvey·DateJan 10, 2024

Key health department jobs don’t exist, according to the federal government

Several key public health occupations, including disease intervention specialist and program manager, do not have valid SOC matches, creating challenges in researching the workforce. The study's findings highlight the need for standardization to characterize the public health workforce linked to SOC codes.

SourceColumbia University's Mailman School of Public Health·JournalAmerican Journal of Public Health·DateDec 20, 2023

C-Path’s pioneering neuroscience workshop transforms the landscape of neurological disorder therapies

The C-Path Neuroscience Annual Workshop brought together stakeholders to chart a transformative course for neurology research and drug development, focusing on chronic progressive diseases such as Alzheimer's and Parkinson's. Key highlights included recommendations for innovative therapies and tools to address complex disorders.

SourceCritical Path Institute (C-Path)·JournalNeurotherapeutics·TypeContent analysis·DateNov 9, 2023

Engineers from the UMA develop more accessible and versatile next-gen “digital twins”

Researchers from the UMA developed an open-source platform called Open Twins to create more accessible and versatile digital twins. This platform enables the simulation of real-world assets based on virtual replicas, predicting future behaviors and detecting anomalies, leading to more efficient companies that make data-driven decisions.

SourceUniversity of Malaga·JournalComputers in Industry·TypeComputational simulation/modeling·DateOct 27, 2023

BioOne and SPIE publish case study on nonprofit platform partnership

A new case study explores the early years of BioOne and SPIE's nonprofit platform partnership, highlighting its potential to reduce costs and enhance strategic development. The authors share key lessons learned, including the importance of regular communication and reciprocal service-level agreements.

SourceBioOne·JournalLearned Publishing·TypeCase study·DateDec 7, 2022

Aging | Lamin A to Z in normal aging

A new study suggests that prelamin A, a precursor of lamin A, accumulates with age and may drive normal aging. Researchers propose this protein as a target for intervention strategies to extend healthspan and lifespan.

SourceImpact Journals LLC·JournalAging-US·TypeCommentary/editorial·DateNov 9, 2022

Oncotarget | Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer

A study using mRNA and miRNA expression profiles identified molecular signatures that can differentiate muscle invasive bladder cancer patients who respond to neoadjuvant chemotherapy from those who do not. The research found distinct gene pathways and subtypes associated with response, which may lead to more effective treatment delivery.

SourceImpact Journals LLC·JournalOncotarget·TypeData/statistical analysis·DateNov 8, 2022

Oncotarget | The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells

Researchers found that overexpressing matriptase reduced myeloma cell proliferation and inhibited migration. Matriptase also blocked Src kinase activation, supporting its potential as a tumor suppressor in multiple myeloma. The study provides new insights into the role of matriptase in hematological malignancies.

SourceImpact Journals LLC·JournalOncotarget·TypeObservational study·DateNov 7, 2022

eLife ends accept/reject decisions following peer review

eLife is ending its practice of making accept/reject decisions following peer review, instead publishing every paper it reviews as a Reviewed Preprint. This new model restores control to authors, promoting the assessment of scientists based on their research output rather than publication venue.

SourceeLife·DateOct 20, 2022

Current FDA oversight of vaping industry likely to have minimal impact

The FDA's warning letters issued in 2020 and 2021 revealed that the regulator is failing to target leading tobacco companies and products most popular among young people. Over 90% of warnings were sent to small online retailers, while flavoured refillable e-cigarette liquids accounted for over 90% of the products cited.

SourceBMJ Group·JournalTobacco Control·TypeData/statistical analysis·DateOct 13, 2022

The Lancet Global Health: Industry arguments against alcohol labelling influencing policy discussions at World Trade Organisation, study suggests

A qualitative study found that industry arguments against alcohol health warning labels were cited by World Trade Organization representatives, despite not being explicitly stated as industry demands. This highlights the need for greater transparency and curbing the alcohol industry's influence on global policy implementation.

SourceThe Lancet·JournalThe Lancet Global Health·TypeCase study·DateFeb 1, 2022

World-leading pharma collaborates call for plain language summaries of peer-reviewed medical journal articles

Pharmaceutical companies in the Open Pharma collaboration recommend developing plain language summaries of peer-reviewed medical research articles. The summaries should be understandable, unbiased, non-promotional, and easily accessible. This move aims to make medical publishing more open and inclusive for all audiences.

SourceTaylor & Francis Group·JournalCurrent Medical Research and Opinion·TypeCommentary/editorial·DateSep 12, 2021

Can encroachment benefit hotel franchisees?

Researchers found that adding a new outlet can modestly benefit existing locations in markets with few same-brand outlets, leading to increased revenues and profits. The study's findings suggest prioritizing markets with few same-brand outlets, newer brands, cross-brands, and online travel agency sales channels for expansion.

SourceAmerican Marketing Association·JournalJournal of Marketing·DateJun 15, 2021

Drug trial protocol redactions by industry sponsors exposed

Researchers found widespread redactions in commercially sponsored trial protocols, making them useless for assessing ethical justification and identifying discrepancies with publications. The study highlights the mistrust in industry-sponsored drug trials and calls for unconditional access to trial protocols and data.

SourceSAGE·JournalJournal of the Royal Society of Medicine·DateJan 26, 2018

Prions made in SISSA

Scientists at SISSA create synthetic prion series for the first time, allowing precise control over their pathogenic behavior. The study verifies that these synthetic prions cause illness comparable to natural ones, paving the way for potential treatments for neurodegenerative diseases.

BIO World Congress on Industrial Biotechnology names Industrial Biotechnology its official journal

The BIO World Congress on Industrial Biotechnology has selected Industrial Biotechnology as its official journal, providing readers with more in-depth coverage of the industry's science, technology, markets, and policy efforts. The partnership aims to tell compelling stories of industrial biotech development and innovation.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalIndustrial Biotechnology·DateMay 7, 2015

Independent safety investigation needed in the NHS

A new agency would investigate major failures and provide public explanation, improving system-wide learning. The NHS lacks a consistent approach to investigating safety issues, relying on costly one-off inquiries.

SourceSAGE·JournalJournal of the Royal Society of Medicine·DateOct 30, 2014